23 Feb Avectas
Michael Maguire, CEO
Oct. 6 | 1:45pm | FLW Ballroom F
Dublin, Ireland
(Private)
Driving scalable and affordable cell therapy, Avectas is transforming manufacturing with Solupore® Integrated, a flexible, integrated manufacturing platform that enables affordable cell therapies.
The Solupore Integrated platform is a consumable based closed platform that reduces costs, facility footprint while driving access and affordability to cell therapy patients.
Solupore offers a single platform that supports development to clinic to commercial manufacturing.
By shifting from single-use instruments to scale-out simplicity, reducing manual touchpoints, and delivering platforms that are intuitive and flexible, Avectas accelerates the clinical translation of life-saving therapies and unlocks the full potential of next-generation cell engineering.
Avectas is a private, international company with research facilities in Dublin and an office in Cambridge MA, USA. It has 24 employees and is led by a team of highly experienced pharmaceutical executives and supported by a world-class Scientific Advisory Board of cancer cell therapy experts.